Universal Pharmaceutical Industries (UNIPHARMA)
Universal Pharmaceutical Industries, widely known by its abbreviation UNIPHARMA, is a prominent and established pharmaceutical company specializing in the manufacturing of a diverse range of medicinal and healthcare products. Established in 1990 as a limited family company under the Syrian Investment Law, the entity's core mission is to provide high-quality pharmaceutical and health care products that offer value in terms of quality, convenience, and cost-effectiveness. The company's large facility is located approximately 15 kilometers from Damascus, strategically positioned along the Jordan Highway.
Continue…Core Business and Operations
UNIPHARMA's operations are deeply rooted in the pharmaceutical industry, functioning as a manufacturer, importer, exporter, marketer, and co-promoter of both national and multinational pharmaceutical products. The company???s business model is realized through the local manufacturing of its own branded generic products, as well as producing branded products under licensing agreements with reputable international pharmaceutical firms, such as SOLVAY Pharmaceuticals B.V. and Vifor international Inc. Switzerland.
The production facility spans a significant area, constructed in compliance with the stringent Good Manufacturing Practice (GMP) standards set by the World Health Organization (WHO), and benefits from cooperation with experts from top international pharmaceutical companies to ensure quality control and assurance.
The firm operates a balanced, technologically-driven system that integrates administration, production, marketing, and promotion. It continuously strives to develop and apply electronic communication systems and computer programs across most of its activities. The manufacturing processes employ the latest standards to ensure that the scientifically advanced, high-quality, safe, and effective products are produced at a competitive cost.
Products and Product Lines
UNIPHARMA offers a comprehensive portfolio of products that cover a broad spectrum of therapeutic fields, addressing key areas of medical need. The company's finished pharmaceutical products are manufactured in a variety of dosage forms, utilizing dedicated production lines.
Therapeutic Categories Covered
The company's product line addresses major treatment areas, including:
* Cardio-vascular medicines: Medications for heart and blood vessel conditions.
* Central Nervous System (CNS) medicines: Treatments for neurological and psychiatric disorders.
* Respiratory Tract medicines: Products for conditions affecting the lungs and airways.
* Gastrointestinal medicines: Pharmaceutical solutions for digestive system issues.
* Metabolism Disturbance medicines: Drugs targeting metabolic disorders.
* Anti-biotics and Antiseptics: Essential medicines for combating bacterial infections and for sterilization.
* Dermatological medicines: Topical treatments for skin conditions.
Dosage Forms and Production Lines
The state-of-the-art manufacturing facility is equipped to produce a wide array of pharmaceutical forms, including:
* Capsules
* Plain Tablets
* Sugar Coated Tablets & Slow Absorbed Tablets
* Effervescent Tablets
* Syrups & Suspensions (liquid oral forms)
* Dermatological and Eye Creams & Ointments (topical and ophthalmological preparations)
* Dent paste (dental care products)
* Medical shampoo
Services and Quality Assurance
A key component of UNIPHARMA's service is its commitment to high-level quality assurance and control. The plant construction was done in full compliance with GMP standards. The company has successfully acquired GMP certifications from the Russian Federation Ministry of Health (MOH) and the National Medicinal Board at the Sudan MOH, in addition to the GMP approval from the Syrian Ministry of Health. Furthermore, the company has been awarded the ISO 9001/2015 certification and is in the final stages of being awarded ISO 14001 and ISO 45001, demonstrating its commitment to quality management, environmental responsibility, and occupational health and safety.
The company's services also extend to robust distribution and export:
* Distribution: Employing a wide distribution network to ensure high-quality manufactured products reach Syrian customers at the lowest possible cost.
* Export: Actively working to export its manufactured pharmaceutical products to international markets through a professional system that involves using top agents and a well-trained promotional team, targeting medical corporations in various countries.
* Research & Development (R&D) Focus: The company maintains a vision to be a leading pharmaceutical entity with a strong R&D division dedicated to developing its own new product formulas, alongside maintaining the top quality of its existing product line.
In summary, Universal Pharmaceutical Industries is a major manufacturing force in the Middle East's pharmaceutical sector, providing comprehensive medical solutions from product development and licensed manufacturing to extensive distribution and export services across a vast range of therapeutic classes.
